Short Interest in ASP Isotopes Inc. (NASDAQ:ASPI) Grows By 104.3%

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 15,300,000 shares, an increase of 104.3% from the January 15th total of 7,490,000 shares. Based on an average daily volume of 3,810,000 shares, the days-to-cover ratio is currently 4.0 days. Currently, 28.2% of the company's stock are sold short.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ASPI. Nuveen Asset Management LLC lifted its stake in ASP Isotopes by 672.1% in the fourth quarter. Nuveen Asset Management LLC now owns 413,346 shares of the company's stock valued at $1,872,000 after buying an additional 359,811 shares during the last quarter. Millennium Management LLC bought a new stake in ASP Isotopes in the 4th quarter valued at about $55,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in ASP Isotopes by 33.5% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,904 shares of the company's stock valued at $131,000 after purchasing an additional 7,250 shares during the period. Deutsche Bank AG grew its position in ASP Isotopes by 25.2% in the 4th quarter. Deutsche Bank AG now owns 33,587 shares of the company's stock worth $152,000 after purchasing an additional 6,763 shares during the last quarter. Finally, Bank of America Corp DE grew its position in ASP Isotopes by 318.7% in the 4th quarter. Bank of America Corp DE now owns 113,084 shares of the company's stock worth $512,000 after purchasing an additional 86,075 shares during the last quarter. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI traded down $0.41 during trading on Monday, reaching $5.29. The stock had a trading volume of 1,541,834 shares, compared to its average volume of 2,274,993. The stock has a market cap of $377.65 million, a PE ratio of -8.67 and a beta of 3.51. The firm's 50 day moving average price is $5.26 and its two-hundred day moving average price is $4.49. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. ASP Isotopes has a one year low of $1.86 and a one year high of $9.33.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.